Showing results (131-140 of 181) with videos related to

Sort By:
Pageof 19
Arthritis & Rheumatology (Hoboken, N.J.)|July 4, 2024
Association of Autoantibody Concentrations and Trajectories With Lupus Nephritis Histologic Features and Treatment ResponseAndrea Fava, Catriona A Wagner, Carla J Guthridge, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2026
EBV reprograms autoreactive anti-CNS B cells as antigen presenting cells in multiple sclerosisShady Younis, Sajede Rasouli, Jacob W Loeffler, et al.
Nature|November 23, 2007
RAG2 PHD finger couples histone H3 lysine 4 trimethylation with V(D)J recombinationAdam G W Matthews, Alex J Kuo, Santiago Ramón-Maiques, et al.
Biorxiv : the Preprint Server for Biology|September 2, 2025
Persistent Immune Dysregulation during Post-Acute Sequelae of COVID-19 is Manifested in Antibodies Targeting Envelope and Nucleocapsid ProteinsMarcin Kwissa, Manikannan Mathayan, Satyajeet S Salunkhe, et al.
Science Translational Medicine|June 28, 2013
Plasmid-encoded proinsulin preserves C-peptide while specifically reducing proinsulin-specific CD8⁺ T cells in type 1 diabetesBart O Roep, Nanette Solvason, Peter A Gottlieb, et al.
The Journal of Clinical Investigation|November 26, 2013
Protein microarray analysis reveals BAFF-binding autoantibodies in systemic lupus erythematosusJordan V Price, David J Haddon, Dodge Kemmer, et al.
Archives of Neurology|August 19, 2007
Induction of antigen-specific tolerance in multiple sclerosis after immunization with DNA encoding myelin basic protein in a randomized, placebo-controlled phase 1/2 trialAmit Bar-Or, Timothy Vollmer, Jack Antel, et al.
Biorxiv : the Preprint Server for Biology|April 15, 2024
Distinct Type 1 Immune Networks Underlie the Severity of Restrictive Lung Disease after COVID-19Glenda Canderan, Lyndsey M Muehling, Alexandra Kadl, et al.
The Journal of Clinical Investigation|October 28, 2021
The intersection of COVID-19 and autoimmunityJason S Knight, Roberto Caricchio, Jean-Laurent Casanova, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2026
CD38 defines a therapeutically targetable pathogenic T cell population for precision immunotherapy in autoimmune diabetesShiva Pathak, Rizwan Ahmed, Nadine Nagy, et al.
Pageof 19